Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer

Wenbo Xu(Shenyang Institute of Automation), Zhilong Dong(Lanzhou University Second Hospital), Long Cheng(Boston Children's Hospital), Yongjin Yang(Lanzhou University Second Hospital), Liangliang Qing(Lanzhou University Second Hospital), Qingchao Li(Shandong Normal University), Longtu Ma(Lanzhou University Second Hospital), Shuai Liu(Lanzhou University Second Hospital)
Computers in Biology and Medicine
August 13, 2024
10.1016/j.compbiomed.2024.108989
Cited by 13

Related Papers

A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
|Cell|2020|802
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease
|Cell|2020|715